Related Experiment Video
Updated: Jun 3, 2025

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
METTL3-Mediated m6A Modification of ISG15 mRNA Regulates Doxorubicin-Induced Endothelial Cell Apoptosis
Dongdong Jian1,2, Han Li3,4, Chenqiu Wang3
1Department of Biochemistry and Molecular Biology, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Abstract:
N6-adenosine methylation (m6A) of RNA is involved in the regulation of various diseases. However, its role in chemotherapy-related vascular endothelial injury has not yet been elucidated. We found that methyltransferase-like 3 (METTL3) expression was significantly reduced during doxorubicin (DOX)-induced apoptosis of vascular endothelial cells both in vivo and in vitro, and that silencing of METTL3 further intensified this process. Combined transcriptome and proteome sequencing analyses revealed that the expression levels of interferon-stimulated gene 15 (ISG15) mRNA and protein significantly increased after METTL3 silencing. Methylated RNA immunoprecipitation (meRIP)-quantitative polymerase chain reaction (qPCR) and mRNA stability assays confirmed that METTL3 regulates the expression of ISG15 by methylating the 1,014,147 site on ISG15 RNA, thereby decreasing ISG15 mRNA levels. Silencing ISG15 significantly suppressed DOX-induced endothelial cell apoptosis and dysfunction caused by METTL3 silencing. In summary, our study revealed that METTL3-mediated methylation of ISG15 mRNA is involved in DOX-induced endothelial cell apoptosis and explored potential therapeutic targets for alleviating chemotherapy-associated vascular injury.
Insights
Methyltransferase-like 3 (METTL3) protects against doxorubicin-induced vascular injury by methylating interferon-stimulated gene 15 (ISG15) RNA. This m6A modification reduces ISG15 levels, preventing endothelial cell apoptosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- N6-adenosine methylation (m6A) regulates diverse biological processes and diseases.
- The role of m6A in chemotherapy-induced vascular endothelial injury remains unclear.
Purpose of the Study:
- To investigate the role of methyltransferase-like 3 (METTL3) in doxorubicin (DOX)-induced vascular endothelial injury.
- To elucidate the molecular mechanism by which METTL3 affects endothelial cell apoptosis.
Main Methods:
- In vivo and in vitro models of DOX-induced vascular endothelial injury.
- Transcriptome and proteome sequencing.
- Methylated RNA immunoprecipitation (meRIP)-qPCR and mRNA stability assays.
- Gene silencing techniques (METTL3 and ISG15).
Main Results:
- METTL3 expression decreased in DOX-treated vascular endothelial cells, exacerbating apoptosis.
- METTL3 silencing led to increased interferon-stimulated gene 15 (ISG15) mRNA and protein levels.
- METTL3 directly methylated ISG15 RNA at site 1,014,147, reducing ISG15 mRNA stability.
- ISG15 knockdown attenuated DOX-induced endothelial cell apoptosis and dysfunction.
Conclusions:
- METTL3-mediated m6A modification of ISG15 mRNA is a key mechanism in DOX-induced endothelial cell apoptosis.
- METTL3-ISG15 pathway represents a potential therapeutic target for chemotherapy-associated vascular injury.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nuclear Export of mRNA

